| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
|
| Product Name: | GELATINASE B | | Synonyms: | GELATINASE (92KDA);GELATINASE (92KDA) PROENZYME;HUMAN MATRIX METALLOPROTEINASE 9;HUMAN MMP-9;HUMAN GELATINASE B;MATRIX METALLOPROTEINASE 9;MATRIX METALLOPROTEINASE MATRIX METALLOPROTEINASE-9;95 KDA GELATINASE | | CAS: | 146480-36-6 | | MF: | | | MW: | 0 | | EINECS: | 231-449-2 | | Product Categories: | | | Mol File: | Mol File | ![GELATINASE B Structure]() |
| | GELATINASE B Chemical Properties |
| storage temp. | −70°C | | form | buffered aqueous solution | | biological source | mouse |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 23-26-36 | | WGK Germany | 1 | | Storage Class | 10 - Combustible liquids |
| | GELATINASE B Usage And Synthesis |
| Uses | All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit . | | Biochem/physiol Actions | MMP-9 degrades the collagens that make up the extracellular matrix, which has a role in the control of angiogenesis. | | Description | MMP-9 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 338 amino acids fragment (113-450) corresponding to the catalytic domain of the protein, having a total molecular mass of 42.03kDa and fused with a 4.5kDa amino-terminal hexahistidine tag.
The MMP-9 is purified by proprietary chromatographic techniques. | | Source | Escherichia Coli | | Background | Matrix metalloproteinases are a family of zinc and calcium-dependent endopeptidases that break down extracellular matrix proteins. The MMP9 is secreted as a 92kDa zymogen. Cleavage of ProMMP-9 results in the active enzyme, having a molecular weight of approximately 82kDa. MMP9 is composed of the following domains: a gelatin-binding domain consisting of three fibronectin type II units, a catalytic domain containing the zinc-binding site, a proline-rich type V collagen-homologous domain and a hemopexin-like domain. MMP9 is produced by the several cell types: monocytes, macrophages, neutrophils, keratinocytes, fibroblasts, osteoclasts and endothelial cells. MMP9 is involved in inflammatory responses, tissue remodeling, wound healing, tumor growth and metastasis. MMP9 may also play an important part in local proteolysis of the extracellular matrix and in leukocyte migration, as well as in bone osteoclastic resorption. MMP9 cleaves type IV and type V collagens into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. MMP9 can also degrade fibronectin but not laminin or Pz-peptide.
MMP9 defects may be a cause of susceptibility to intervertebral disc disease (IDD), also known as lumbar disk herniation (LDH). |
| | GELATINASE B Preparation Products And Raw materials |
|